CLOV vs MRVI · rev $1.37B vs rev $259.2M
Clover Health Investments Corp (CLOV) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MRVI revenue for 2024-12-31 was $259.2M. Net income was -$259.6M. MRVI currently screens at market cap $1.93B.
CLOV currently screens at market cap $1.55B. MRVI currently screens at market cap $1.93B.
Not investment advice. Open the CLOV and MRVI stock pages for the full models.
Not investment advice.